Suporn Chuncharunee

Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

Jesús F. San Miguel, Vânia Hungria, Sung‐Soo Yoon et al. · The Lancet Oncology · 2014 · 781 citations

Hematological Malignancy, Double-blind Phase 3, Medicine +9

International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers

Paul Kirk, Taigang He, Lisa Anderson et al. · Journal of Magnetic Resonance Imaging · 2010 · 157 citations · Full text

Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study

Alì Taher, John B. Porter, Vip Viprakasit et al. · Blood · 2012 · 141 citations · Full text

A scoring system for the classification of β‐thalassemia/Hb E disease severity

Orapan Sripichai, Wattanan Makarasara, Thongperm Munkongdee et al. · American Journal of Hematology · 2008 · 141 citations · Full text

Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/β‐thalassaemic patients*

Vichai Atichartakarn, Pantep Angchaisuksiri, Katcharin Aryurachai et al. · British Journal of Haematology · 2002 · 124 citations